Joseph Howard Senesac
Chief Tech/Sci/R&D Officer chez BELLICUM PHARMACEUTICALS, INC.
Profil
Joseph Howard Senesac is currently the Senior VP-Technical Operations & Quality at Bellicum Pharmaceuticals, Inc. He previously worked as the Associate Director-Process Sciences at Introgen Therapeutics, Inc., the Senior Director-Biologics Manufacturing at Precigen, Inc., the Principal at Rhone-Poulenc Rorer, Inc., and the Principal at Promega Corp.
He completed his undergraduate degree at Knox College and holds an MBA from The University of Colorado.
Postes actifs de Joseph Howard Senesac
Sociétés | Poste | Début |
---|---|---|
BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Joseph Howard Senesac
Sociétés | Poste | Fin |
---|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
Promega Corp.
Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Corporate Officer/Principal | - |
INTROGEN THERPUT | Corporate Officer/Principal | - |
PRECIGEN, INC. | Corporate Officer/Principal | - |
Formation de Joseph Howard Senesac
Knox College | Undergraduate Degree |
The University of Colorado | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PRECIGEN, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Introgen Therapeutics, Inc.
Introgen Therapeutics, Inc. Medical SpecialtiesHealth Technology Introgen Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company develops molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. The company maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility. It was founded in June 1993 and is headquartered in Austin, TX. | Health Technology |
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Promega Corp.
Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Health Technology |